title: Stem cell treatments for neurodegenerative diseases: challenges from a science, business and healthcare perspective.
authors.forename: Achim
authors.initials: A
authors.lastname: Rosemann
mesh_terms: D002986:Clinical Trials as Topic / Q000191:economics; D006801:Humans; D009313:National Health Programs / Q000191:economics; D019636:Neurodegenerative Diseases / Q000191:economics* / Q000503:physiopathology / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000191:economics* / Q000941:ethics / Q000379:methods*; D013234:Stem Cells / Q000502:physiology*
keywords: IPS cells; access to medicines; affordability; healthcare decisions; neurodegenerative diseases; stem cell medicine